Maryland and Montgomery County have announced support for the new U.S. headquarters of Autolus, a U.K.-based biopharmaceutical company focused on discovering and developing treatments for cancer. The company plans to create approximately 170 new jobs by 2021. A leader in T-cell programming and manufacturing technology, the company will also have research and development and manufacturing operations in Rockville.
“Autolus is delighted to base its U.S. headquarters in Montgomery County, Maryland. With its educated and diverse workforce and proximity to world-class research facilities and universities, Montgomery County was the natural choice for us to base our U.S. hub,” said Matthias Alder, senior vice president and chief business officer of Autolus.
Autolus will host its operations at its new 85,000-square-foot Rockville facility located on Medical Center Drive; commercial real estate company JLL represented the company in the project. Based in London, Autolus was founded in 2014 as a spin out from University College London. Over the past four years, the company has continued to develop its pipeline of autologous blood cancer and solid tumor T cell programs.
READ FULL ARTICLE HERE
